evipedia.ai
← Back

Pramiracetam for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Pramiracetam, a memory drug approved in parts of Europe, unapproved in the United States, is used to protect or sharpen memory. Small, old studies point toward better memory after brain injury or age-related memory complaints, not in Alzheimer's disease. No trial has tested enhancement in healthy people at usual doses; nothing links it to longer life. Side effects appear mostly mild; with grey-market products, quality may be the larger risk. (Full Review)

Protocol

Label regimen
600 mg twice daily
1,200 mg/day for memory and attention disorders of vascular or degenerative origin
Time of day
Morning and midday
Common practice; avoids label-listed insomnia
Baseline biomarkers
Creatinine clearance guides dose
Older adults with reduced kidney function may need lower doses
Time to effect
Clinical effects
4–8 weeks
Per prescribing information
Drug-induced memory loss
10 days
Partial offset of scopolamine-induced memory impairment in healthy men
Non-response
8 weeks
No measurable change from baseline by 8 weeks suggests non-response

Benefits

Contraindications
  • Severe kidney failure
  • Pregnancy and breastfeeding
  • Known hypersensitivity to pramiracetam
  • Epilepsy or prior seizures (inferred; no controlled human data)
  • Athletes in drug-tested sport (pramiracetam presumed covered)
    •
Key Interactions
  • Anticholinergic drugs (scopolamine)
    •
Theoretical (inferred from mechanism)
  • Other anticholinergic drugs (diphenhydramine, oxybutynin)
  • Acetylcholinesterase inhibitors (donepezil, rivastigmine) and huperzine A
  • Corticosteroids (prednisone)
  • Aldosterone antagonists (spironolactone)
  • Stimulants (caffeine, modafinil)
  • Seizure-threshold-lowering drugs (bupropion)
  • NSAIDs (ibuprofen) and other kidney-impairing drugs
  • Antiplatelet and anticoagulant drugs (aspirin, warfarin) and ginkgo
  • Other racetams (piracetam, aniracetam) and choline supplements (alpha-GPC)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Insomnia, agitation and anxiety; Gastrointestinal discomfort; Rare neurological reactions; Mislabeled or adulterated grey-market products
    •
  • Speculative: Bleeding tendency; Unknown long-term safety in healthy users
    •

Monitoring

Marker Target Why
Serum creatinine with eGFR Men 0.74–1.35 mg/dL; women 0.59–1.04 mg/dL Safety: kidney clearance governs exposure
Delayed word-list recall score No established target; track change from own baseline Main improved measure
Pregnancy test (women of reproductive potential) Negative Safety: pregnancy contraindicates use

Cadence: Baseline before starting (memory test twice); memory retest at 4 and 8 weeks, then every 6 months; kidney function at 8 weeks, then every 6–12 months, or sooner when kidney-affecting drugs are started

Qualitative Assessment

  • Sleep onset time and sleep quality
  • Restlessness, anxiety or irritability
  • Everyday memory lapses (names, appointments, misplaced items)
  • Mental clarity and sustained focus during demanding tasks
  • Stomach comfort and appetite
  • Headache frequency
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.